A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
Completed · Phase 2 · Has a placebo group
Conditions studied: Acute Pain
In brief
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of VX-993 in treating acute pain after a bunionectomy.
Key facts
- Study ID
- NCT06619847
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 367
- Starts
- 2024-10-29
- Expected to finish
- 2025-05-27
- Last updated by the study team
- 2026-05-28
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Shoals Medical Trials Inc. — Sheffield, Alabama, United States
- Arizona Research Center — Phoenix, Arizona, United States
- Woodland International Research Group — Little Rock, Arkansas, United States
- Trovare Clinical Research — Bakersfield, California, United States
- New Hope Research Development | Tarzana, CA — Tarzana, California, United States
- Clinical Pharmacology of Miami — Miami, Florida, United States
- ForCare Clinical Research — Tampa, Florida, United States
- Atlanta Center for Medical Research — Atlanta, Georgia, United States
- BioBehavioral Research of Austin — Austin, Texas, United States
- HD Research LLC | First Surgical Hospital — Bellaire, Texas, United States
- HD Research LLC | Legent Orthopedic Hospital — Carrollton, Texas, United States
- Memorial Hermann Village — Houston, Texas, United States
- Endeavor Clinical Trials — San Antonio, Texas, United States
- JBR Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.